cupric oxide
Small moleculeexperimental
Copper(II) oxide or cupric oxide is an inorganic compound with the formula CuO. A black solid, it is one of the two stable oxides of copper, the other being Cu2O or copper(I) oxide (cuprous oxide). As a mineral, it is known as tenorite, or sometimes black copper. It is a product of copper mining and the precursor to many other copper-containing products and chemical compounds. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2017 (NCT02393183)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- CopperSupplementation
Copper supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCopper(II) oxide ↗
Also known as
- copper oxide
- copper oxide
- copper oxide
- cupric oxide
- cupric oxide
- cupric oxide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02393183 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2017 | Isfahan University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Isfahan University | Academic/Hospital | 1 | 1 | 1 | 2017 |
1 organizations
Page 1 / 1